Skip to main content

Table 1 Strategies for individualization of glycemic targets

From: Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain

Category name

HbA1c target

Low/high risk

Patient characteristics

   

Treatment

Previous hypoglycemia

Age

Duration of diabetes

Diabetes complicationsa

ADA/EASD- 1

<6.5

Low

Any

Any

Any

<5

No

ADA/EASD-2

<7

Low

Any

Any

≤75

5-9

No

ADA/EASD-3

<8

High

Any

Any

>75

Any

Any

Any

>10

Any

Any

Any

Yes

SED-1

≤6.5

Low

Any

Any

≤70

<10

No

SED-2

≤7.5

High

Any

Any

>70

Any

Any

Any

>10

Any

Any

Any

Yes

HYPO-1

<7

Low

Not insulin, not SU, not glinides

No

Any

Any

Any

HYPO-2

<7.5

Low

Basal insulin, SU, or glinides

No

Any

Any

Any

HYPO-3

<8

High

Insulin (≥2 doses)

Any

Any

Any

Any

Any

Yes

Any

Any

Any

  1. aDiabetes complications for ADA/EASD and SED categories were considered to be macroalbuminuria (urine albumin-creatinine ratio of >300 mg/g), chronic kidney disease (CKD), diabetic foot, diabetic retinopathy, polyneuropathy, peripheral vascular disease, cerebrovascular disease or coronary vascular disease
  2. SU: sulphonylureas